412 related articles for article (PubMed ID: 28922426)
1. A DNA vaccine for Crimean-Congo hemorrhagic fever protects against disease and death in two lethal mouse models.
Garrison AR; Shoemaker CJ; Golden JW; Fitzpatrick CJ; Suschak JJ; Richards MJ; Badger CV; Six CM; Martin JD; Hannaman D; Zivcec M; Bergeron E; Koehler JW; Schmaljohn CS
PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005908. PubMed ID: 28922426
[TBL] [Abstract][Full Text] [Related]
2. Immunization with DNA Plasmids Coding for Crimean-Congo Hemorrhagic Fever Virus Capsid and Envelope Proteins and/or Virus-Like Particles Induces Protection and Survival in Challenged Mice.
Hinkula J; Devignot S; Åkerström S; Karlberg H; Wattrang E; Bereczky S; Mousavi-Jazi M; Risinger C; Lindegren G; Vernersson C; Paweska J; van Vuren PJ; Blixt O; Brun A; Weber F; Mirazimi A
J Virol; 2017 May; 91(10):. PubMed ID: 28250124
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside-Modified mRNA Vaccines Protect IFNAR
Appelberg S; John L; Pardi N; Végvári Á; Bereczky S; Ahlén G; Monteil V; Abdurahman S; Mikaeloff F; Beattie M; Tam Y; Sällberg M; Neogi U; Weissman D; Mirazimi A
J Virol; 2022 Feb; 96(3):e0156821. PubMed ID: 34817199
[TBL] [Abstract][Full Text] [Related]
4. Co-Delivery Effect of CD24 on the Immunogenicity and Lethal Challenge Protection of a DNA Vector Expressing Nucleocapsid Protein of Crimean Congo Hemorrhagic Fever Virus.
Aligholipour Farzani T; Hanifehnezhad A; Földes K; Ergünay K; Yilmaz E; Hashim Mohamed Ali H; Ozkul A
Viruses; 2019 Jan; 11(1):. PubMed ID: 30658445
[TBL] [Abstract][Full Text] [Related]
5. Bovine Herpesvirus Type 4 (BoHV-4) Vector Delivering Nucleocapsid Protein of Crimean-Congo Hemorrhagic Fever Virus Induces Comparable Protective Immunity against Lethal Challenge in IFNα/β/γR-/- Mice Models.
Aligholipour Farzani T; Földes K; Hanifehnezhad A; Yener Ilce B; Bilge Dagalp S; Amirzadeh Khiabani N; Ergünay K; Alkan F; Karaoglu T; Bodur H; Ozkul A
Viruses; 2019 Mar; 11(3):. PubMed ID: 30857305
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the cell culture based and the mouse brain derived inactivated vaccines against Crimean-Congo hemorrhagic fever virus in transiently immune-suppressed (IS) mouse model.
Pavel STI; Yetiskin H; Kalkan A; Ozdarendeli A
PLoS Negl Trop Dis; 2020 Nov; 14(11):e0008834. PubMed ID: 33226988
[TBL] [Abstract][Full Text] [Related]
7. Viral replicon particles protect IFNAR
Spengler JR; Welch SR; Scholte FEM; Rodriguez SE; Harmon JR; Coleman-McCray JD; Nichol ST; Montgomery JM; Bergeron É; Spiropoulou CF
Antiviral Res; 2021 Jul; 191():105090. PubMed ID: 34044061
[TBL] [Abstract][Full Text] [Related]
8. A Crimean-Congo hemorrhagic fever (CCHF) viral vaccine expressing nucleoprotein is immunogenic but fails to confer protection against lethal disease.
Dowall SD; Buttigieg KR; Findlay-Wilson SJ; Rayner E; Pearson G; Miloszewska A; Graham VA; Carroll MW; Hewson R
Hum Vaccin Immunother; 2016; 12(2):519-27. PubMed ID: 26309231
[TBL] [Abstract][Full Text] [Related]
9. Vesicular Stomatitis Virus-Based Vaccine Protects Mice against Crimean-Congo Hemorrhagic Fever.
Rodriguez SE; Cross RW; Fenton KA; Bente DA; Mire CE; Geisbert TW
Sci Rep; 2019 May; 9(1):7755. PubMed ID: 31123310
[TBL] [Abstract][Full Text] [Related]
10. Heterologous protection against Crimean-Congo hemorrhagic fever in mice after a single dose of replicon particle vaccine.
Spengler JR; Welch SR; Scholte FEM; Coleman-McCray JD; Harmon JR; Nichol ST; Bergeron É; Spiropoulou CF
Antiviral Res; 2019 Oct; 170():104573. PubMed ID: 31377243
[TBL] [Abstract][Full Text] [Related]
11. Construction and evaluation of DNA vaccine encoding Crimean Congo hemorrhagic fever virus nucleocapsid protein, glycoprotein N-terminal and C-terminal fused with LAMP1.
Hu YL; Zhang LQ; Liu XQ; Ye W; Zhao YX; Zhang L; Qiang ZX; Zhang LX; Lei YF; Jiang DB; Cheng LF; Zhang FL
Front Cell Infect Microbiol; 2023; 13():1121163. PubMed ID: 37026060
[TBL] [Abstract][Full Text] [Related]
12. Structure and Characterization of Crimean-Congo Hemorrhagic Fever Virus GP38.
Mishra AK; Moyer CL; Abelson DM; Deer DJ; El Omari K; Duman R; Lobel L; Lutwama JJ; Dye JM; Wagner A; Chandran K; Cross RW; Geisbert TW; Zeitlin L; Bornholdt ZA; McLellan JS
J Virol; 2020 Mar; 94(8):. PubMed ID: 31996434
[TBL] [Abstract][Full Text] [Related]
13. Nucleocapsid protein-based vaccine provides protection in mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
Zivcec M; Safronetz D; Scott DP; Robertson S; Feldmann H
PLoS Negl Trop Dis; 2018 Jul; 12(7):e0006628. PubMed ID: 30011277
[TBL] [Abstract][Full Text] [Related]
14. Crimean-Congo Hemorrhagic Fever Virus Subunit Vaccines Induce High Levels of Neutralizing Antibodies But No Protection in STAT1 Knockout Mice.
Kortekaas J; Vloet RP; McAuley AJ; Shen X; Bosch BJ; de Vries L; Moormann RJ; Bente DA
Vector Borne Zoonotic Dis; 2015 Dec; 15(12):759-64. PubMed ID: 26684523
[TBL] [Abstract][Full Text] [Related]
15. A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model.
Buttigieg KR; Dowall SD; Findlay-Wilson S; Miloszewska A; Rayner E; Hewson R; Carroll MW
PLoS One; 2014; 9(3):e91516. PubMed ID: 24621656
[TBL] [Abstract][Full Text] [Related]
16. Pseudo-plaque reduction neutralization test (PPRNT) for the measurement of neutralizing antibodies to Crimean-Congo hemorrhagic fever virus.
Canakoglu N; Berber E; Ertek M; Yoruk MD; Tonbak S; Bolat Y; Aktas M; Kalkan A; Ozdarendeli A
Virol J; 2013 Jan; 10():6. PubMed ID: 23282186
[TBL] [Abstract][Full Text] [Related]
17. GP38-targeting monoclonal antibodies protect adult mice against lethal Crimean-Congo hemorrhagic fever virus infection.
Golden JW; Shoemaker CJ; Lindquist ME; Zeng X; Daye SP; Williams JA; Liu J; Coffin KM; Olschner S; Flusin O; Altamura LA; Kuehl KA; Fitzpatrick CJ; Schmaljohn CS; Garrison AR
Sci Adv; 2019 Jul; 5(7):eaaw9535. PubMed ID: 31309159
[TBL] [Abstract][Full Text] [Related]
18. Development of a Novel Multi-Epitope Vaccine Against Crimean-Congo Hemorrhagic Fever Virus: An Integrated Reverse Vaccinology, Vaccine Informatics and Biophysics Approach.
Tahir Ul Qamar M; Ismail S; Ahmad S; Mirza MU; Abbasi SW; Ashfaq UA; Chen LL
Front Immunol; 2021; 12():669812. PubMed ID: 34220816
[TBL] [Abstract][Full Text] [Related]
19. A DNA-based vaccine protects against Crimean-Congo haemorrhagic fever virus disease in a Cynomolgus macaque model.
Hawman DW; Ahlén G; Appelberg KS; Meade-White K; Hanley PW; Scott D; Monteil V; Devignot S; Okumura A; Weber F; Feldmann H; Sällberg M; Mirazimi A
Nat Microbiol; 2021 Feb; 6(2):187-195. PubMed ID: 33257849
[TBL] [Abstract][Full Text] [Related]
20. Replicating RNA vaccination elicits an unexpected immune response that efficiently protects mice against lethal Crimean-Congo hemorrhagic fever virus challenge.
Leventhal SS; Meade-White K; Rao D; Haddock E; Leung J; Scott D; Archer J; Randall S; Erasmus JH; Feldmann H; Hawman DW
EBioMedicine; 2022 Aug; 82():104188. PubMed ID: 35907368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
